150 related articles for article (PubMed ID: 15365443)
1. American Burkitt's lymphoma of the head and neck: evaluation with serial FDG-PET.
Chander S; Webster GC; Zingas AP; Zak IT; Joyrich RN; Zerin JM; Bloom DA; Littrup PJ
Clin Nucl Med; 2004 Oct; 29(10):646-8. PubMed ID: 15365443
[No Abstract] [Full Text] [Related]
2. Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt's lymphoma.
Wei WX; Huang JJ; Li WY; Zhang X; Xia Y; Jiang WQ; Fan W; Li ZM
Chin J Cancer; 2015 Dec; 34(12):608-13. PubMed ID: 26630874
[TBL] [Abstract][Full Text] [Related]
3. Bilateral breasts involvement in Burkitt's lymphoma detected only by FDG-PET.
Kyoung Jung H; Kim EK; Yun M; Jung Kim M; Young Kwak J
Clin Imaging; 2006; 30(1):57-9. PubMed ID: 16377487
[TBL] [Abstract][Full Text] [Related]
4. False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt's lymphoma.
Riad R; Omar W; Sidhom I; Zamzam M; Zaky I; Hafez M; Abdel-Dayem HM
Nucl Med Commun; 2010 Mar; 31(3):232-8. PubMed ID: 20032800
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET and PET/CT in Burkitt's lymphoma.
Karantanis D; Durski JM; Lowe VJ; Nathan MA; Mullan BP; Georgiou E; Johnston PB; Wiseman GA
Eur J Radiol; 2010 Jul; 75(1):e68-73. PubMed ID: 19716248
[TBL] [Abstract][Full Text] [Related]
6. [Value of Pretherapeutic
Ding CY; Liu HY; Guo Z; Li TN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):438-443. PubMed ID: 28446289
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
Kubota K; Yokoyama J; Yamaguchi K; Ono S; Qureshy A; Itoh M; Fukuda H
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):590-5. PubMed ID: 14722678
[TBL] [Abstract][Full Text] [Related]
8. Giant primary breast Burkitt's lymphoma demonstrated on FDG PET/CT.
Liu Y
Breast J; 2020 May; 26(5):1039-1040. PubMed ID: 31777132
[No Abstract] [Full Text] [Related]
9. Atypical
Childs L; Thompson A; Jones H; Hameeduddin A; Ghufoor K; Adams A
Clin Imaging; 2018; 49():136-143. PubMed ID: 29414508
[TBL] [Abstract][Full Text] [Related]
10. The value of F-18 FDG triple-head coincidence PET in the posttreatment evaluation of patients with lymphoma.
Huić D; Mutvar A; Radman I; Grosev D; Labar B; Zuvić M; Dodig D; Aurer I; Nemet D
Clin Nucl Med; 2006 May; 31(5):275-8. PubMed ID: 16622336
[No Abstract] [Full Text] [Related]
11. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer.
Platzek I
PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244
[TBL] [Abstract][Full Text] [Related]
12. Pediatric nonendemic Burkitt's lymphoma of the head and neck.
Vinayak BC; Reddy KT; Fulton J; Milford CA
Ann Otol Rhinol Laryngol; 1994 Mar; 103(3):238-40. PubMed ID: 8122841
[No Abstract] [Full Text] [Related]
13. The prognostic value of FDG PET in head and neck cancer. Correlation with histopathology.
Döbert N; Kovács AF; Menzel C; Hamscho N; Yuen Yuen H; Engels K; Walendzik H; Grünwald F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):253-7. PubMed ID: 16172571
[TBL] [Abstract][Full Text] [Related]
14. Burkitt's Lymphoma Involving Multiple Hormone-Producing Organs on FDG PET/CT.
Wen Z; Zhuang H
Clin Nucl Med; 2019 Dec; 44(12):995-997. PubMed ID: 31689284
[TBL] [Abstract][Full Text] [Related]
15. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ
Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma.
Albano D; Bosio G; Pagani C; Re A; Tucci A; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):87-96. PubMed ID: 30276438
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer.
Lalami Y; Garcia C; Flamen P; Ameye L; Paesmans M; Awada A
Head Neck; 2016 Mar; 38(3):347-54. PubMed ID: 25332069
[TBL] [Abstract][Full Text] [Related]
18. FDG PET imaging of head and neck cancers.
Menda Y; Graham MM
Methods Mol Biol; 2011; 727():21-31. PubMed ID: 21331926
[TBL] [Abstract][Full Text] [Related]
19. Burkitt's lymphoma. Two cases in treatment.
Shalhoub SY
Ann Dent; 1987; 46(2):59-62. PubMed ID: 3326516
[No Abstract] [Full Text] [Related]
20. Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond.
Porceddu SV; Burmeister BH; Hicks RJ
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1221-38, ix-x. PubMed ID: 19010270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
